Ambrx Biopharma Inc. Profile Avatar - Palmy Investing

Ambrx Biopharma Inc.

Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (A…

Biotechnology
US, La Jolla [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Ambrx Biopharma Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Ambrx Biopharma Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Ambrx Biopharma Inc..

End of AMAM's Analysis
CIK: 1836056 CUSIP: 02290A102 ISIN: US6418711080 LEI: - UEI: -
Secondary Listings
AMAM has no secondary listings inside our databases.